The most important advances in headache research in 2018-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The most important advances in headache research in 2018

Published:2019-01 Issue:1 Volume:18 Page:5-6
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Ashina Messoud

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference5 articles.

1. The international classification of headache disorders, 3rd edition;Cephalalgia,2018

2. Effect of fremanezumab compared with placebo for prevention of episodic migraine: a randomized clinical trial;Dodick;JAMA,2018

3. Evaluation of galcanezumab for the prevention of episodic migraine: the EVOLVE-1 randomized clinical trial;Stauffer;JAMA Neurol,2018

4. Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study;Reuter;Lancet,2018

5. Activation of pial and dural macrophages and dendritic cells by cortical spreading depression;Schain;Ann Neurol,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders;The Journal of Headache and Pain;2024-01-04

2. Preventive treatment of migraine: Non-specific oral agents;Handbook of Clinical Neurology;2024

3. Mitochondrial sensitive probe with aggregation‐induced emission characteristics for early brain diagnosis of Parkinson's disease;Aggregate;2023-08-08

4. Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine;Toxins;2022-08-01

5. Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy;The Journal of Headache and Pain;2021-07-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3